Thirty States Draft More Than 60 Drug-Price Transparency Bills

By John Wilkerson / August 23, 2017 at 3:18 PM
Thirty states have drafted more than 60 drug price transparency bills aimed at identifying drug maker expenses and unveiling business practices of pharmacy benefit managers, according to an analysis by the National Academy for State Health Policy. Most of the action to stem prescription drug price increases is taking place in the states, which are dealing with strained budgets. Avalere Health reported in May on the uptick . At the time, the group said 17 states, plus Puerto Rico, were...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.